Perspectives of Italian Employers Regarding the Return to Work Process of Employees Who Received a Cancer Diagnosis: a Qualitative Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-01

Study Completion Date

2027-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

European Cancer Mission calls attention to the return to work (RTW) of cancer survivors (CSs), as one of the pivotal issues of the cancer continuum that need to be addressed through proper and prompt actions and recommendations. Employers are important stakeholders, as they can provide emotional and practical support, sustain communication during the entire process, and guarantee a gradual work reintegration. In Italy there is lack of knowledge regarding this topic. Thus, further exploration of Italian employers' perspectives on the RTW of employees with cancer should be performed to comprehend their unknown experiences.

The aim is to explore the perspectives of employers who dealt with the RTW process of employees who received a cancer diagnosis through a qualitative research design.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Facilitate the Return to Work of Cancer Survivors

NCT03666936

Neoplasms Return to Work

COMPLETED NA

Adaptation and First Step Validation of the ICF Core Set for Vocational Rehabilitation for Cancer Survivors

NCT04439461

Cancer Survivors

COMPLETED

The Unmet Needs and the Workplace Reintegration of Breast Cancer Patients: the NEW-BreCa Project

NCT05309252

Breast Cancer Breast Neoplasms

COMPLETED

The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia

NCT06236373

Cancer Breast Cancer Prostate Cancer +5 more

RECRUITING

Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes

NCT03961217

Gynecologic Cancer Prostate Cancer Radiation Toxicity +5 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Data collection will be performed through individual semi-structured interviews. Each interview will last around 60 minutes, and it can be arranged in person or remotely, depending on the participant's preference. Socio-demographic data, expertise of the employer, and company-related data will be collected through a semi-structured interview.

Experiences of employers will be collected through open-ended questions using an interview guide that was written based on the one used by Tiedtke et al., 2017, by adding some questions related to the facilitators and barriers perceived by employers during the sickness absence and RTW of employee with cancer.

The open-ended questions will concern general information about the company, employers' experience after cancer disclosure and during sick leave, employers' experience to sustain the RTW process and the long-term work reintegration, and the influence of the experience on the company.

Each interview will be audio-recorded, transcribed verbatim and analyzed according to the thematic analysis method using an inductive approach with open coding.

Analysis will be iterative and involve multiple researchers to ensure inter-rater reliability of the coding procedure and the methodological rigor of the analysis.

Themes generated will be discussed with Dutch researchers from the Amsterdam University Medical Centers.

Analyses will be carried out at the end of each interview because, based on the themes that will emerge from each interview, we will understand when to stop recruiting.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Survivors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Employers

This cohort includes employers of active companies located in the province of Reggio Emilia. The Chamber of Commerce dell 'Emilia will provide a random list of the active company based on the type of company (profit, non-for-profit), type of sector (i.e., manufacturing, constructions), and number of employees (small, medium, large) to guarantee the representativeness of our context.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. employers\* of a company
2. being directly involved in managing the RTW process of at least one employee with cancer diagnosis in the last 5 years.

* An employer can be the specific person who represents the company where the employee was working at the time of cancer diagnosis or a person who supported the employee during the sickness absence and the RTW process (e.g., line manager, human resource manager).